Genis

Genís is a biotechnology company developing new methods to treat inflammatory and degenerative diseases, primarily in bone and cartilage tissue, but also in other tissues of the body. The company’s focus is threefold: Developing methods to use amino sugars to enhance the healing capacity of damaged bone tissue with implant materials in surgical procedures. Creating sugar-based compounds that can be administered orally to counteract tissue damage caused by inflammation. Conducting research aimed at shedding light on the processes underlying the biological activity of amino sugars. Genís works extensively with both domestic and international scientists and has run collaborative projects with numerous universities and companies. Genís was founded by Hólshyrna ehf.